U.S. Gastroenterology Ambulatory Surgery Center Market Share Analysis Report, 2023-2032
The U.S. gastroenterology ambulatory surgery center market size was estimated at USD 8.6 billion in 2022 and is expected to hit around USD 15.29 billion by 2032, poised to reach at a notable CAGR of 5.92% during the forecast period 2023 to 2032.
Key Takeaways:
U.S. Gastroenterology Ambulatory Surgery Center Market Report Scope
| Report Attribute | Details |
| Market Size in 2023 | USD 9.11 Billion |
| Market Size by 2032 | USD 15.29 Billion |
| Growth Rate From 2023 to 2032 | CAGR of 5.92% |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | Ownership |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Report Coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Key Companies Profiled | Cardinal Health; Medtronic PLC; Ethicon (Johnson & Johnson); Boston Scientific; Olympus; Becton Dickinson (BD); Hill-Rom Holdings; GE Healthcare; Koninklijke Philips N.V.; Cook Medical |
Growing incidences of gastrointestinal disorders, rising geriatric population, overcrowding of the Hospital Outpatient Department (HOPD), and rising preference for ambulatory services to avoid unnecessary hospitalization charges are the major factors driving the market growth. According to the American Hospital Association's (AHA) 2022 Hospital Statistics report, in 2020, the outpatient revenue increased significantly and was around 95% of the inpatient revenue. This was mainly due to reduced inpatient admissions as compared to outpatient visits. The overall outpatient visits increased by 1.2% year-on-year while the hospital admission increased by less than 1%. This slowdown in hospital admissions shows the rising preference of the patients toward Ambulatory Surgery Centers (ASCs).
Rising healthcare costs are a major concern disrupting the industry and with it comes the fact that not all patients are capable to afford the cost of treatment that they need. This issue has forced healthcare service providers to find out an alternative to provide high-quality treatment at an affordable price. ASCs have proven to be an effective solution in this scenario. In the U.S., visits to ASCs for the treatment of gastrointestinal diseases are steadily increasing. Gastroenterology is one of the most common surgical specialties in multi- and single-specialty ASCs.
Medicare is the largest payer for ambulatory services in the country. From January 2020, Centers for Medicare and Medicaid Services (CMS) increased the reimbursement rate for endomicroscopy in upper GI endoscopy procedures in hospitals and in ambulatory surgical centers. Since ASCs include low admin cost but no hospitalization cost, ASC remains a more profitable business for the physicians when compared to hospitals. According to the Definitive Healthcare data, in 2017, ASCs performed more than 7.7 million Medicare procedures.
Ownership Insights
On the basis of ownership, the U.S. gastroenterology ambulatory surgery center market has been segmented into hospital-affiliated, freestanding/physician-owned, corporation-owned, and others. The other segment includes ventures between physician-hospital, physician-corporation, and physician-corporation-hospital. The freestanding segment (mainly comprising physician-owned ambulatory surgery centers) accounted for the highest market share in 2018, owing to maximum professional control over the clinical environment and quality of care delivered to patients. It allows physicians to focus on a small number of procedures in a single setting. With hands-on control, physicians maintain quality control processes in ASCs within a smaller space and fewer operating rooms as compared to hospitals.
The rising burden of surgical procedures in the hospital increases the demand for ASC to perform various procedures such as urology, gastrointestinal, and ophthalmic surgery. Endoscopic Ambulatory Surgery Centers (EASC) are the freestanding facilities designated to carry out gastrointestinal procedures at a low cost. These facilities are more competent than the hospital and offer an added source of revenue to the healthcare providers. According to Becker’s review of GI and Endoscopy in ASCs, in the U.S., around 25% of all cases in ASCs involve GI/endoscopic procedures. Also, more than 27% of all the single-specialty surgery centers are driven due to gastroenterology procedure
Regional Insights
The high adoption rate of advanced surgical procedures such as minimally invasive surgeries and new endoscopy technologies are the key factors driving the ambulatory surgery centers market in U.S. In addition, the high cost of medical services offered by physicians in the country and unnecessary hospitalization, create the need for cost-effective and efficient treatment options for patients seeking treatment. According to the data published by The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), 60 to 70 million people suffer from gastrointestinal diseases each year in U.S. The most common diseases include Gastroesophageal Reflux Disease (GERD), Irritable Bowel Syndrome (IBS), indigestion, constipation, diarrhea, and abdominal pain.
Some of the prominent players in the U.S. Gastroenterology Ambulatory Surgery Center Market include:
Segments Covered in the Report
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2032. For this study, Nova one advisor, Inc. has segmented the U.S. Gastroenterology Ambulatory Surgery Center market.
By Ownership
Chapter 1 Methodology and Scope
1.1 Market Segmentation & Scope
1.1.1 Ownership
1.1.2 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database
1.3.2 nova one advisor internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity flow approach
1.6.2 Volume price analysis (Model 2)
1.6.2.1 Approach 2: Volume price analysis
1.7 List of Secondary Sources
1.8 List of Abbreviations
1.9 Objectives
1.9.1 Objective - 1
1.9.2 Objective - 2
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.2.1 Ownership
2.3 Competitive Insights
Chapter 3 Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.1.2 Related/ancillary market outlook
3.2 Market Segmentation
3.2.1 Analysis
3.3 Penetration & Growth Prospect Mapping
3.3.1 Penetration analysis
3.4 Regulatory & Reimbursement Framework
3.4.1 Ambulatory services regulations in the U.S.
3.5 Technological Trends and Recent Advancements
3.6 Market Dynamics
3.6.1 Market driver analysis
3.6.1.1 Cost-effectiveness due to increase in reimbursement rate
3.6.1.2 Increasing utilization of technology for minimally invasive procedures
3.6.2 Market restraint analysis
3.6.2.1 Safety issues and regulatory concerns
3.6.2.2 Operational uncertainty
3.7 U.S. Gastroenterology Ambulatory Surgery Center (ASC) Market: Business Environment Analysis Tools
3.7.1 U.S. gastroenterology Ambulatory Surgery Center (ASC) Market: PORTER’s Five Forces Analysis
3.7.2 U.S. gastroenterology Ambulatory Surgery Center (ASC) Market: PESTLE Analysis
3.7.3 Major deals & strategic alliances analysis
3.7.3.1 Mergers & acquisitions and joint ventures
3.7.3.2 Licensing & partnerships and technology collaborations
Chapter 4 U.S. Gastroenterology Ambulatory Surgery Center (ASC) Market: Ownership Analysis
4.1 U.S. Gastroenterology Ambulatory Surgery Center (ASC) Ownership Market Share Analysis, 2018 & 2032
4.2 U.S. Gastroenterology Ambulatory Surgery Centers Ownership Market: Segment Dashboard:
4.3 Market Size & Forecasts and Trend Analysis, Ownership Segment 2020 to 2032
4.3.1 Hospital-affiliated
4.3.1.1 Hospital-affiliated market, 2020 - 2032
4.3.2 Freestanding
4.3.2.1 Freestanding market, 2020 - 2032
4.3.3 Corporation-owned
4.3.3.1 Corporation-owned market, 2020 - 2032
4.3.4 Others
4.3.4.1 Others market, 2020 - 2032
Chapter 5 U.S. Gastroenterology Ambulatory Surgery Center (ASC) Market: Regional Analysis
5.1 U.S.
5.1.1 U.S. gastroenterology ambulatory surgery center market, 2020 - 2032
Chapter 6 Competitive Analysis
6.1 Strategic Framework/Competition Categorization (Key innovators, market leaders, emerging players)
6.2 Vendor Landscape
6.2.1 Company market position analysis, by manufacturer (Overall revenue, product portfolio, geographic presence, employee strength, & strategic initiatives,)
6.2.1.1 Analysis
6.2.2 Company market position analysis, by service provider (Market presence, service portfolio, employee strength & strategic initiatives)
6.2.2.1 Analysis
6.3 Company Profiles
6.3.1 By manufacturer
6.3.1.1 Cardinal Health
6.3.1.1.1 Company overview
6.3.1.1.2 Financial performance
6.3.1.1.3 Product benchmarking
6.3.1.1.4 Strategic initiatives
6.3.1.1.5 SWOT analysis
6.3.1.2 Boston Scientific Corporation
6.3.1.2.1 Company overview
6.3.1.2.2 Financial performance
6.3.1.2.3 Product benchmarking
6.3.1.2.4 Strategic initiatives
6.3.1.2.5 SWOT analysis
6.3.1.3 GE Healthcare
6.3.1.3.1 Company overview
6.3.1.3.2 Financial performance
6.3.1.3.3 Product benchmarking
6.3.1.3.4 Strategic initiatives
6.3.1.3.5 SWOT analysis
6.3.1.4 Koninklijke Philips N.V.
6.3.1.4.1 Company overview
6.3.1.4.2 Financial performance
6.3.1.4.3 Product benchmarking
6.3.1.4.4 Strategic initiatives
6.3.1.4.5 SWOT analysis
6.3.1.5 Cook Medical
6.3.1.5.1 Company overview
6.3.1.5.2 Financial overview
6.3.1.5.3 Product benchmarking
6.3.1.5.4 Strategic initiatives
6.3.1.5.5 SWOT analysis
6.3.1.6 Hill-Rom Holding Inc
6.3.1.6.1 Company overview
6.3.1.6.2 Financial performance
6.3.1.6.3 Product benchmarking
6.3.1.6.4 Strategic initiatives
6.3.1.6.5 SWOT analysis
6.3.1.7 Medtronic PLC
6.3.1.7.1 Company overview
6.3.1.7.2 Financial performance
6.3.1.7.3 Product benchmarking
6.3.1.7.4 Strategic initiatives
6.3.1.7.5 SWOT analysis
6.3.1.8 Becton, Dickinson and Company
6.3.1.8.1 Company overview
6.3.1.8.2 Financial performance
6.3.1.8.3 Product benchmarking
6.3.1.8.4 Strategic initiatives
6.3.1.8.5 SWOT anlysis
6.3.1.9 Johnson & Johnson Services, Inc.
6.3.1.9.1 Company overview
6.3.1.9.2 Financial performance
6.3.1.9.3 Product benchmarking
6.3.1.9.4 Strategic initiatives
6.3.1.9.5 SWOT analysis
6.3.1.10 Olympus Corporation
6.3.1.10.1 Company overview
6.3.1.10.2 Financial performance
6.3.1.10.3 Product benchmarking
6.3.1.10.4 Strategic initiatives
6.3.1.10.5 SWOT analysis
6.3.2 By service provider
6.3.2.1 Envision Healthcare Corporation
6.3.2.1.1 Company overview
6.3.2.1.2 Financial performance
6.3.2.1.3 Services benchmarking
6.3.2.1.4 Strategic initiatives
6.3.2.1.5 SWOT analysis
6.3.2.2 Surgical Care Affiliates, Inc. (SCA)
6.3.2.2.1 Company overview
6.3.2.2.2 Financial performance
6.3.2.2.3 Services benchmarking
6.3.2.2.4 Strategic initiatives
6.3.2.2.5 SWOT analysis
6.3.2.3 Surgery Partners
6.3.2.3.1 Company overview
6.3.2.3.2 Financial performance
6.3.2.3.3 Services benchmarking
6.3.2.3.4 Strategic initiatives
6.3.2.3.5 SWOT analysis
6.3.2.4 Tenet Healthcare Corporation
6.3.2.4.1 Company overview
6.3.2.4.2 Financial performance
6.3.2.4.3 Services benchmarking
6.3.2.4.4 Strategic initiatives
6.3.2.4.5 SWOT analysis
6.3.2.5 Universal Health Services, Inc.
6.3.2.5.1 Company overview
6.3.2.5.2 Financial performance
6.3.2.5.3 Services benchmarking
6.3.2.5.4 Strategic initiatives
6.3.2.5.5 SWOT analysis
6.3.2.6 Community Health Systems, Inc.
6.3.2.6.1 Company overview
6.3.2.6.2 Financial performance
6.3.2.6.3 Services benchmarking
6.3.2.6.4 Strategic initiatives
6.3.2.6.5 SWOT analysis
6.3.2.7 HCA Healthcare, Inc.
6.3.2.7.1 Company overview
6.3.2.7.2 Financial performance
6.3.2.7.3 Services benchmarking
6.3.2.7.4 Strategic initiatives
6.3.2.7.5 SWOT analysis
6.3.2.8 Covenant Surgical Partners
6.3.2.8.1 Company overview
6.3.2.8.2 Financial performance
6.3.2.8.3 Services benchmarking
6.3.2.8.4 Strategic initiatives
6.3.2.9 SurgCenter Development
6.3.2.9.1 Company overview
6.3.2.9.2 Financial performance
6.3.2.9.3 service benchmarking
6.3.2.9.4 Strategic initiatives
6.3.2.10 Regent Surgical Health
6.3.2.10.1 Company overview
6.3.2.10.2 Financial performance
6.3.2.10.3 Services benchmarking
6.3.2.10.4 Strategic initiatives
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers